{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:26:23Z","timestamp":1792682783127,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.intimp.2023.109755","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T18:32:20Z","timestamp":1675103540000},"page":"109755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Role of chemokine receptor 2 in rheumatoid arthritis: A research update"],"prefix":"10.1016","volume":"116","author":[{"given":"Weile","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10086","key":"10.1016\/j.intimp.2023.109755_b0005","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2023.109755_b0010","first-page":"174","article-title":"Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Practice & Research","volume":"32","author":"van der Woude","year":"2018","journal-title":"Clin. Rheumatol."},{"issue":"10086","key":"10.1016\/j.intimp.2023.109755_b0015","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","article-title":"Novel treatment strategies in rheumatoid arthritis","volume":"389","author":"Burmester","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2023.109755_b0020","first-page":"129","article-title":"Hypersensitivity reactions during treatment with biological agents","volume":"34","author":"Puxeddu","year":"2016","journal-title":"Clin. Exp. Rheumatol"},{"issue":"3","key":"10.1016\/j.intimp.2023.109755_b0025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/bjd.14776","article-title":"Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts","volume":"176","author":"Garcia-Doval","year":"2017","journal-title":"Br. J. Dermatol"},{"issue":"1","key":"10.1016\/j.intimp.2023.109755_b0030","first-page":"29","article-title":"Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice","volume":"36","author":"Leon","year":"2018","journal-title":"Clin. Exp. Rheumatol"},{"key":"10.1016\/j.intimp.2023.109755_b0035","doi-asserted-by":"crossref","first-page":"8644","DOI":"10.1038\/ncomms9644","article-title":"CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells","volume":"6","author":"Kara","year":"2015","journal-title":"Nat. Commun"},{"key":"10.1016\/j.intimp.2023.109755_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103207","article-title":"Analysis of rheumatoid- vs psoriatic arthritis synovial fluid reveals differential macrophage (CCR2) and T helper subsets (STAT3\/4 and FOXP3) activation","author":"Caso","year":"2022","journal-title":"Autoimmun. Rev"},{"issue":"1","key":"10.1016\/j.intimp.2023.109755_b0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2741\/s53","article-title":"Chemokines and chemokine receptors in arthritis","volume":"2","author":"Szekanecz","year":"2010","journal-title":"Front. Biosci. (Schol. Ed)"},{"key":"10.1016\/j.intimp.2023.109755_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.812431","article-title":"Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease","volume":"13","author":"She","year":"2022","journal-title":"Front. Immunol"},{"issue":"16","key":"10.1016\/j.intimp.2023.109755_b0055","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS. J."},{"issue":"1","key":"10.1016\/j.intimp.2023.109755_b0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrrheum.2015.157","article-title":"Successes and failures of chemokine-pathway targeting in rheumatoid arthritis","volume":"12","author":"Szekanecz","year":"2016","journal-title":"Nat. Rev. Rheumatol"},{"issue":"7","key":"10.1016\/j.intimp.2023.109755_b0065","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1073\/pnas.91.7.2752","article-title":"Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails","volume":"91","author":"Charo","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"1","key":"10.1016\/j.intimp.2023.109755_b0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13578-022-00787-6","article-title":"Analysis of CCR2 splice variant expression patterns and functional properties","volume":"12","author":"Park","year":"2022","journal-title":"Cell. Biosci"},{"issue":"9","key":"10.1016\/j.intimp.2023.109755_b0075","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.4049\/jimmunol.165.9.4877","article-title":"Functional differences between monocyte chemotactic protein-1 receptor A and monocyte chemotactic protein-1 receptor B expressed in a Jurkat T cell","volume":"165","author":"Sanders","year":"2000","journal-title":"J. Immunol"},{"issue":"12","key":"10.1016\/j.intimp.2023.109755_b0080","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1002\/art.11344","article-title":"Chemokine receptor expression and in vivo signaling pathways in the joints of rats with adjuvant-induced arthritis","volume":"48","author":"Shahrara","year":"2003","journal-title":"Arthritis. Rheum."},{"issue":"11","key":"10.1016\/j.intimp.2023.109755_b0085","first-page":"2205","article-title":"Increased monocyte chemoattractant protein-1 in knee joints of rats with adjuvant-induced arthritis: in vivo microdialysis","volume":"32","author":"Liu","year":"2005","journal-title":"J. Rheumatol"},{"issue":"1","key":"10.1016\/j.intimp.2023.109755_b0090","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1080\/21691401.2019.1661849","article-title":"PTEN negatively regulates the expression of pro-inflammatory cytokines and chemokines of fibroblast-like synoviocytes in adjuvant-induced arthritis","volume":"47","author":"Li","year":"2019","journal-title":"Artif. Cells. Nanomed. Biotechnol"},{"issue":"10","key":"10.1016\/j.intimp.2023.109755_b0095","doi-asserted-by":"crossref","first-page":"18748","DOI":"10.1002\/jcp.28514","article-title":"CCR5 silencing reduces inflammatory response, inhibits viability, and promotes apoptosis of synovial cells in rat models of rheumatoid arthritis through the MAPK signaling pathway","volume":"234","author":"Lan","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.intimp.2023.109755_b0100","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/art.39117","article-title":"CCR2 Expression in Neutrophils Plays a Critical Role in Their Migration Into the Joints in Rheumatoid Arthritis","volume":"67","author":"Talbot","year":"2015","journal-title":"Arthritis. &. Rheumatology"},{"key":"10.1016\/j.intimp.2023.109755_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.767231","article-title":"Preventive CCL2\/CCR2 Axis Blockade Suppresses Osteoclast Activity in a Mouse Model of Rheumatoid Arthritis by Reducing Homing of CCR2(hi) Osteoclast Progenitors to the Affected Bone","volume":"12","author":"Flegar","year":"2021","journal-title":"Front. Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2023.109755_b0110","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13075-017-1337-6","article-title":"Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells","volume":"19","author":"Sucur","year":"2017","journal-title":"Arthritis. Res. Ther"},{"issue":"9","key":"10.1016\/j.intimp.2023.109755_b0115","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.imbio.2011.03.012","article-title":"CD8\u03b1+ dendritic cells improve collagen-induced arthritis in CC chemokine receptor (CCR)-2 deficient mice","volume":"216","author":"Ibarra","year":"2011","journal-title":"Immunobiology"},{"issue":"7","key":"10.1016\/j.intimp.2023.109755_b0120","doi-asserted-by":"crossref","first-page":"e887","DOI":"10.1002\/ctm2.887","article-title":"Involvement of MST1\/mTORC1\/STAT1 activity in the regulation of B-cell receptor signalling by chemokine receptor 2","volume":"12","author":"Zhu","year":"2022","journal-title":"Clin. Transl. Med"},{"key":"10.1016\/j.intimp.2023.109755_b0125","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3389\/fimmu.2018.01852","article-title":"The Critical Role of Chemokine (C-C Motif) Receptor 2-Positive Monocytes in Autoimmune Cholangitis","volume":"9","author":"Reuveni","year":"2018","journal-title":"Front. Immunol"},{"issue":"6","key":"10.1016\/j.intimp.2023.109755_b0130","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1172\/JCI200420126","article-title":"Experimental arthritis in CC chemokine receptor 2\u2013null mice closely mimics severe human rheumatoid arthritis","volume":"113","author":"Quinones","year":"2004","journal-title":"J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.intimp.2023.109755_b0135","doi-asserted-by":"crossref","first-page":"e25833","DOI":"10.1371\/journal.pone.0025833","article-title":"Enhanced Th17-cell responses render CCR2-deficient mice more susceptible for autoimmune arthritis","volume":"6","author":"Rampersad","year":"2011","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.intimp.2023.109755_b0140","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1337-6","article-title":"Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells","volume":"19","author":"Sucur","year":"2017","journal-title":"Arthritis. Res. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2023.109755_b0145","doi-asserted-by":"crossref","first-page":"e000079","DOI":"10.1136\/rmdopen-2015-000079","article-title":"Regulation of peripheral classical and non-classical monocytes on infliximab treatment in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"2","author":"Aeberli","year":"2016","journal-title":"RMD. Open"},{"key":"10.1016\/j.intimp.2023.109755_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01260","article-title":"CD14+ Cells with the Phenotype of Infiltrated Monocytes Consist of Distinct Populations Characterized by Anti-inflammatory as well as Pro-inflammatory Activity in Gouty Arthritis","volume":"8","author":"Jeong","year":"2017","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.109755_b0155","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/path.4466","article-title":"Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A-dependent pro-inflammatory profile","volume":"235","author":"Soler Palacios","year":"2015","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109755_b0160","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00264-013-2121-0","article-title":"Association of systemic and intra-articular osteoclastogenic potential, pro-inflammatory mediators and disease activity with the form of inflammatory arthritis","volume":"38","author":"Iki\u0107","year":"2014","journal-title":"Int. Orthop."},{"issue":"6","key":"10.1016\/j.intimp.2023.109755_b0165","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","article-title":"Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes","volume":"16","author":"Nygaard","year":"2020","journal-title":"Nat. Rev. Rheumatol"},{"key":"10.1016\/j.intimp.2023.109755_b0170","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3389\/fimmu.2018.00749","article-title":"Transcription Factor SOX5 Promotes the Migration and Invasion of Fibroblast-Like Synoviocytes in Part by Regulating MMP-9 Expression in Collagen-Induced Arthritis","volume":"9","author":"Shi","year":"2018","journal-title":"Front. Immunol"},{"issue":"6","key":"10.1016\/j.intimp.2023.109755_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/cells8060561","article-title":"Peficitinib Inhibits the Chemotactic Activity of Monocytes via Proinflammatory Cytokine Production in Rheumatoid Arthritis Fibroblast-Like Synoviocytes","volume":"8","author":"Ikari","year":"2019","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.intimp.2023.109755_b0180","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/emm.2007.55","article-title":"Expression of CCR2A, an isoform of MCP-1 receptor, is increased by MCP-1, CD40 ligand and TGF-beta in fibroblast like synoviocytes of patients with RA","volume":"39","author":"Cho","year":"2007","journal-title":"Exp. Mol. Med"},{"issue":"12","key":"10.1016\/j.intimp.2023.109755_b0185","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1002\/1529-0131(200112)44:12<2750::AID-ART462>3.0.CO;2-C","article-title":"Selective lymphocyte chemokine receptor expression in the rheumatoid joint","volume":"44","author":"Ruth","year":"2001","journal-title":"Arthritis. Rheum"},{"issue":"2","key":"10.1016\/j.intimp.2023.109755_b0190","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1046\/j.1365-3083.2003.01214.x","article-title":"The chemokines CCL5, CCL2 and CXCL12 play significant roles in the migration of Th1 cells into rheumatoid synovial tissue","volume":"57","author":"Shadidi","year":"2003","journal-title":"Scand. J. Immunol"},{"key":"10.1016\/j.intimp.2023.109755_b0195","doi-asserted-by":"crossref","unstructured":"Pelletier M, M.L.M.A., Evidence for a cross-talk between human neutrophils and Th17 cells. Blood., 2010. 2(115): p. 335-43.","DOI":"10.1182\/blood-2009-04-216085"},{"issue":"7639","key":"10.1016\/j.intimp.2023.109755_b0200","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.intimp.2023.109755_b0205","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/rheumatology\/kez169","article-title":"Two populations of circulating PD-1hiCD4 T cells with distinct B cell helping capacity are elevated in early rheumatoid arthritis","volume":"58","author":"Fortea-Gordo","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.intimp.2023.109755_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.654623","article-title":"Human PD-1hiCD8+ T Cells Are a Cellular Source of IL-21 in Rheumatoid Arthritis","volume":"12","author":"Higashioka","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109755_b0215","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/ard.2006.054056","article-title":"Differential effect of methotrexate on the increased CCR2 density on circulating CD4 T lymphocytes and monocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in responders","volume":"66","author":"Ellingsen","year":"2007","journal-title":"Ann. Rheum. Dis"},{"issue":"6","key":"10.1016\/j.intimp.2023.109755_b0220","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/annrheumdis-2014-206028","article-title":"The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis","volume":"74","author":"Boyle","year":"2015","journal-title":"Ann. Rheum. Dis"},{"key":"10.1016\/j.intimp.2023.109755_b0225","doi-asserted-by":"crossref","unstructured":"Xia L, L.J.X.W., Blockage of TNF-\u03b1 by infliximab reduces CCL2 and CCR2 levels in patients with rheumatoid arthritis. J Investig Med., 2011. 6(59): p. 961-3.","DOI":"10.2310\/JIM.0b013e31821c0242"},{"issue":"4","key":"10.1016\/j.intimp.2023.109755_b0230","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/03009742.2012.754937","article-title":"Changes in chemokines and their receptors in blood during treatment with the TNF inhibitor infliximab in patients with rheumatoid arthritis","volume":"42","author":"Eriksson","year":"2013","journal-title":"Scand. J. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109755_b0235","doi-asserted-by":"crossref","first-page":"8238","DOI":"10.1038\/s41598-020-65127-5","article-title":"A new laboratory surrogate (Monocyte Chemotactic Protein-1) for Disease Activity Score28: a favourable indicator for remission in rheumatoid arthritis","volume":"10","author":"Liou","year":"2020","journal-title":"Sci. Rep"},{"key":"10.1016\/j.intimp.2023.109755_b0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2018.05.086","article-title":"Oxidative stress in autoimmune rheumatic diseases","volume":"125","author":"Smallwood","year":"2018","journal-title":"Free. Radic. Biol. Med"},{"issue":"9","key":"10.1016\/j.intimp.2023.109755_b0245","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.imbio.2011.04.001","article-title":"Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis","volume":"216","author":"Shah","year":"2011","journal-title":"Immunobiology"},{"key":"10.1016\/j.intimp.2023.109755_b0250","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaut.2017.06.004","article-title":"Autoreactivity to malondialdehyde-modifications in rheumatoid arthritis is linked to disease activity and synovial pathogenesis","volume":"84","author":"Gronwall","year":"2017","journal-title":"J. Autoimmun"},{"key":"10.1016\/j.intimp.2023.109755_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106554","article-title":"Evaluation of Encapsulated Eugenol by Chitosan Nanoparticles on the aggressive model of rheumatoid arthritis","volume":"85","author":"Jabbari","year":"2020","journal-title":"Int. Immunopharmacol"},{"issue":"1","key":"10.1016\/j.intimp.2023.109755_b0260","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/08916934.2014.939268","article-title":"Markers of inflammation and oxidative stress studied in adjuvant-induced arthritis in the rat on systemic and local level affected by pinosylvin and methotrexate and their combination","volume":"48","author":"Bauerova","year":"2015","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.intimp.2023.109755_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33594\/000000117","article-title":"Oxidative Stress Induces Expression of the Toll-Like Receptors (TLRs) 2 and 4 in the Human Peripheral Blood Mononuclear Cells: Implications for Metabolic Inflammation","volume":"53","author":"Akhter","year":"2019","journal-title":"Cell. Physiol. Biochem"},{"key":"10.1016\/j.intimp.2023.109755_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172663","article-title":"The protective effects of the GPR39 agonist TC-G 1008 against TNF-alpha-induced inflammation in human fibroblast-like synoviocytes (FLSs)","volume":"865","author":"Jing","year":"2019","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.intimp.2023.109755_b0275","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.intimp.2018.09.011","article-title":"Enhanced neutrophil autophagy and increased concentrations of IL-6, IL-8, IL-10 and MCP-1 in rheumatoid arthritis","volume":"65","author":"An","year":"2018","journal-title":"Int. Immunopharmacol"},{"issue":"3","key":"10.1016\/j.intimp.2023.109755_b0280","doi-asserted-by":"crossref","first-page":"H1145","DOI":"10.1152\/ajpheart.01328.2007","article-title":"CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways","volume":"294","author":"Montecucco","year":"2008","journal-title":"Am. J. Physiology-Heart Circulatory Physiol."},{"issue":"6","key":"10.1016\/j.intimp.2023.109755_b0285","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s10753-016-0443-y","article-title":"Novel Piperazino-Enaminones Suppress Pro-Inflammatory Cytokines and Inhibit Chemokine Receptor CCR2","volume":"39","author":"Szollosi","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2023.109755_b0290","doi-asserted-by":"crossref","unstructured":"Nanki T, N.K.H.K., Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Immunol., 2001. 9(167): p. 5381-5.","DOI":"10.4049\/jimmunol.167.9.5381"},{"issue":"9","key":"10.1016\/j.intimp.2023.109755_b0295","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/genes8090221","article-title":"High-Throughput Study of the Effects of Celastrol on Activated Fibroblast-Like Synoviocytes from Patients with Rheumatoid Arthritis","volume":"8","author":"Fang","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.intimp.2023.109755_b0300","doi-asserted-by":"crossref","unstructured":"Rafei M, B.Y.B.E., An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis. J Immunol., 2009. 3(183): p. 1759-66.","DOI":"10.4049\/jimmunol.0900523"},{"issue":"6","key":"10.1016\/j.intimp.2023.109755_b0305","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1021\/jm1012903","article-title":"Discovery, Optimization, and Pharmacological Characterization of Novel Heteroaroylphenylureas Antagonists of C\u2013C Chemokine Ligand 2 Function","volume":"54","author":"Laborde","year":"2011","journal-title":"J. Med. Chem."},{"issue":"175","key":"10.1016\/j.intimp.2023.109755_b0310","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.4049\/jimmunol.175.8.5370","article-title":"H.R.C.M., Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344","volume":"8","author":"Brodmerkel","year":"2005","journal-title":"J. Immunol."},{"issue":"172","key":"10.1016\/j.intimp.2023.109755_b0315","article-title":"C.J.S.M., Dual role of CCR2 during initiation and progression of collagen-induced arthritis: evidence for regulatory activity of CCR2+ T cells","volume":"2","author":"Br\u00fchl","year":"2004","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2023.109755_b0320","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00109-005-0637-5","article-title":"The complex role of the chemokine receptor CCR2 in collagen-induced arthritis: implications for therapeutic targeting of CCR2 in rheumatoid arthritis","volume":"83","author":"Quinones","year":"2005","journal-title":"J. Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.109755_b0325","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbrc.2009.12.025","article-title":"Pharmacological targeting reveals distinct roles for CXCR2\/CXCR1 and CCR2 in a mouse model of arthritis","volume":"391","author":"Min","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.intimp.2023.109755_b0330","doi-asserted-by":"crossref","first-page":"e21772","DOI":"10.1371\/journal.pone.0021772","article-title":"Why CCR2 and CCR5 blockade failed and why CCR1 blockade might still be effective in the treatment of rheumatoid arthritis","volume":"6","author":"Lebre","year":"2011","journal-title":"PLoS. One"},{"issue":"18","key":"10.1016\/j.intimp.2023.109755_b0335","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1570163816666191023103118","article-title":"A.A.A.Z., Influence of \u03b2-D-mannuronic Acid, as a New Member of Non-steroidal Anti- Inflammatory Drugs Family, on the Expression Pattern of Chemokines and their Receptors in Rheumatoid Arthritis","volume":"1","author":"Aslani","year":"2021","journal-title":"Curr. Drug. Discov. Technol."},{"issue":"7","key":"10.1016\/j.intimp.2023.109755_b0340","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/art.23591","article-title":"Modulation of CCR2 in rheumatoid arthritis: A double-blind, randomized, placebo-controlled clinical trial","volume":"58","author":"Vergunst","year":"2008","journal-title":"Arthritis. Rheum."},{"issue":"8","key":"10.1016\/j.intimp.2023.109755_b0345","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/art.21975","article-title":"A randomized controlled trial with an anti-CCL2 (anti\u2013monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis","volume":"54","author":"Haringman","year":"2006","journal-title":"Arthritis. Rheum."},{"issue":"18","key":"10.1016\/j.intimp.2023.109755_b0350","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1007\/s00018-017-2513-1","article-title":"Chemokines in neuron\u2013glial cell interaction and pathogenesis of neuropathic pain","volume":"74","author":"Zhang","year":"2017","journal-title":"Cell. Mol. Life. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.109755_b0355","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/brain\/awh655","article-title":"Modulating CCR2 and CCL2 at the blood\u2013brain barrier: relevance for multiple sclerosis pathogenesis","volume":"129","author":"Mahad","year":"2006","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.intimp.2023.109755_b0360","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/annrheumdis-2014-206921","article-title":"Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis","volume":"75","author":"Yeo","year":"2016","journal-title":"Ann. Rheum. Dis"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923000784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923000784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T12:19:03Z","timestamp":1719231543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923000784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":72,"alternative-id":["S1567576923000784"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109755","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of chemokine receptor 2 in rheumatoid arthritis: A research update","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109755"}}